000 | 05121nam a22006857a 4500 | ||
---|---|---|---|
008 | 240807s20242024 xxu||||| |||| 00| 0 eng d | ||
022 | _a2474-9842 | ||
024 | _a7710789 [pii] | ||
024 | _aPMC11236483 [pmc] | ||
040 | _aOvid MEDLINE(R) | ||
099 | _a38987232 | ||
245 | _aComplications and adverse events in lymphadenectomy of the inguinal area: worldwide expert consensus. | ||
251 | _aBjs Open. 8(4), 2024 Jul 02. | ||
252 | _aBJS open. 8(4), 2024 Jul 02. | ||
253 | _aBJS open | ||
260 | _c2024 | ||
260 | _fFY2025 | ||
260 | _p2024 Jul 02 | ||
265 | _sppublish | ||
265 | _tMEDLINE | ||
266 | _d2024-08-07 | ||
266 | _z2024/07/10 23:02 | ||
520 | _aBACKGROUND: Inguinal lymph node dissection plays an important role in the management of melanoma, penile and vulval cancer. Inguinal lymph node dissection is associated with various intraoperative and postoperative complications with significant heterogeneity in classification and reporting. This lack of standardization challenges efforts to study and report inguinal lymph node dissection outcomes. The aim of this study was to devise a system to standardize the classification and reporting of inguinal lymph node dissection perioperative complications by creating a worldwide collaborative, the complications and adverse events in lymphadenectomy of the inguinal area (CALI) group. | ||
520 | _aCONCLUSION: The complications and adverse events in lymphadenectomy of the inguinal area classification system has been developed as a tool to standardize the assessment and reporting of complications during inguinal lymph node dissection for the treatment of melanoma, vulval and penile cancer. Copyright © The Author(s) 2024. Published by Oxford University Press on behalf of BJS Foundation Ltd. | ||
520 | _aMETHODS: A modified 3-round Delphi consensus approach surveyed a worldwide group of experts in inguinal lymph node dissection for melanoma, penile and vulval cancer. The group of experts included general surgeons, urologists and oncologists (gynaecological and surgical). The survey assessed expert agreement on inguinal lymph node dissection perioperative complications. Panel interrater agreement and consistency were assessed as the overall percentage agreement and Cronbach's alpha. | ||
520 | _aRESULTS: Forty-seven experienced consultants were enrolled: 26 (55.3%) urologists, 11 (23.4%) surgical oncologists, 6 (12.8%) general surgeons and 4 (8.5%) gynaecology oncologists. Based on their expertise, 31 (66%), 10 (21.3%) and 22 (46.8%) of the participants treat penile cancer, vulval cancer and melanoma using inguinal lymph node dissection respectively; 89.4% (42 of 47) agreed with the definitions and inclusion as part of the inguinal lymph node dissection intraoperative complication group, while 93.6% (44 of 47) agreed that postoperative complications should be subclassified into five macrocategories. Unanimous agreement (100%, 37 of 37) was achieved with the final standardized classification system for reporting inguinal lymph node dissection complications in melanoma, vulval cancer and penile cancer. | ||
546 | _aEnglish | ||
650 | _a*Consensus | ||
650 | _a*Delphi Technique | ||
650 | _a*Inguinal Canal | ||
650 | _a*Lymph Node Excision | ||
650 | _a*Melanoma | ||
650 | _a*Penile Neoplasms | ||
650 | _a*Postoperative Complications | ||
650 | _a*Vulvar Neoplasms | ||
650 | _aFemale | ||
650 | _aHumans | ||
650 | _aInguinal Canal/su [Surgery] | ||
650 | _aLymph Node Excision/ae [Adverse Effects] | ||
650 | _aLymph Node Excision/mt [Methods] | ||
650 | _aMale | ||
650 | _aMelanoma/pa [Pathology] | ||
650 | _aMelanoma/su [Surgery] | ||
650 | _aPenile Neoplasms/pa [Pathology] | ||
650 | _aPenile Neoplasms/su [Surgery] | ||
650 | _aPostoperative Complications/ep [Epidemiology] | ||
650 | _aPostoperative Complications/et [Etiology] | ||
650 | _aSurveys and Questionnaires | ||
650 | _aVulvar Neoplasms/pa [Pathology] | ||
650 | _aVulvar Neoplasms/su [Surgery] | ||
650 | _zAutomated | ||
651 | _aMedStar Franklin Square Medical Center | ||
656 | _aSurgery | ||
657 | _aJournal Article | ||
700 |
_aSayegh, Aref S _bMFSMC |
||
790 | _aSotelo R, Sayegh AS, Medina LG, Perez LC, La Riva A, Eppler MB, Gaona J, Tobias-Machado M, Spiess PE, Pettaway CA, Lima Pompeo AC, Lima Mattos PA, Wilson TG, Villoldo GM, Chung E, Samaniego A, Ornellas AA, Pinheiro V, Brazao ES Jr, Subira-Rios D, Koifman L, Zequi SC, Pontillo Z HM, Rodrigues Calixto JR, Campos Silva R, Smithers BM, Garzon S, Haase O, Sommariva A, Fruscio R, Martins F, de Oliveira PS, Levi Sandri GB, Clementi M, Astigueta J, Metwally IH, Bharathan R, Jindal T, Nakamura Y, Abdel Mageed H, Jeevarajan S, Rodriguez Lay R, Garcia-Perdomo HA, Rodriguez Gonzalez O, Ghodoussipour S, Gill I, Cacciamani GE | ||
856 |
_uhttps://dx.doi.org/10.1093/bjsopen/zrae056 _zhttps://dx.doi.org/10.1093/bjsopen/zrae056 |
||
858 |
_ySayegh, Aref S _uhttps://orcid.org/0000-0001-9320-2987 _zhttps://orcid.org/0000-0001-9320-2987 |
||
942 |
_cART _dArticle |
||
999 |
_c14542 _d14542 |